Jane E. Kiernan - 05 Aug 2021 Form 4 Insider Report for Axonics, Inc.

Role
Director
Signature
/s/ Dan Dearen, as Attorney-in-Fact for Jane E. Kiernan
Issuer symbol
N/A
Transactions as of
05 Aug 2021
Net transactions value
-$72,248
Form type
4
Filing time
07 Jul 2022, 20:20:31 UTC
Previous filing
28 May 2021
Next filing
02 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $210,400 +10,000 +132% $21.04 17,594 05 Aug 2021 Direct
transaction AXNX Common Stock Options Exercise $142,095 +4,167 +24% $34.10 21,761 05 Aug 2021 Direct
transaction AXNX Common Stock Sale $109,742 -1,750 -8% $62.71 20,011 01 Apr 2022 Direct F1
transaction AXNX Common Stock Sale $315,000 -5,250 -26% $60.00 14,761 05 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -4,167 -100% $0.000000* 0 05 Aug 2021 Common Stock 4,167 $34.10 Direct F2
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -10,000 -100% $0.000000* 0 05 Aug 2021 Common Stock 10,000 $21.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 The shares subject to the option will vest in full on August 22, 2020.
F3 The shares subject to the option will vest in full on April 8, 2020.